RELATIVE BIOAVAILABILITY OF IMMEDIATE-RELEASE AND SUSTAINED-RELEASE HYDRALAZINE FORMULATIONS

被引：9

作者：

LUDDEN, TM

ROTENBERG, KS

LUDDEN, LK

SHEPHERD, AMM

WOODWORTH, JR

机构：

[1] PENNWALT CORP,ROCHESTER,NY 14623

[2] UNIV TEXAS,HLTH SCI CTR,DEPT PHARMACOL,SAN ANTONIO,TX 78284

[3] HAZLETON LABS AMER,W PALM BEACH,FL 33409

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1988年 / 77卷 / 12期

关键词：

D O I：

10.1002/jps.2600771208

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1026 / 1032

页数：7

共 24 条

[1]

CLEMENTI WA, 1982, J PHARMACOL EXP THER, V222, P159

[2] DETERMINANTS OF SYSTEMIC AVAILABILITY OF ORAL HYDRALAZINE IN HEART-FAILURE [J].

CRAWFORD, MH ;

LUDDEN, TM ;

KENNEDY, GT .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :538-543

[3]

DANIELSON M, 1983, ACTA MED SCAND, V214, P373

[4] DETERMINATION OF HYDRALAZINE AND ITS ACETYLATED METABOLITES IN URINE BY GAS-CHROMATOGRAPHY AND HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].

FACCHINI, V ;

STREETER, AJ ;

TIMBRELL, JA .

JOURNAL OF CHROMATOGRAPHY, 1980, 187 (01) :218-223

[5] DETERMINATION OF HYDRALAZINE IN PLASMA BY GAS-LIQUID-CHROMATOGRAPHY [J].

JACK, DB ;

BRECHBUHLER, S ;

DEGEN, PH ;

ZBINDEN, P ;

RIESS, W .

JOURNAL OF CHROMATOGRAPHY, 1975, 115 (01) :87-92

[6]

LIEDHOLM H, 1982, Drug-Nutrient Interactions, V1, P293

[7] DETERMINATION OF HYDRALAZINE IN HUMAN WHOLE-BLOOD [J].

LUDDEN, TM ;

LUDDEN, LK ;

WADE, KE ;

ALLERHEILIGEN, SRB .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (06) :693-695

[8]

MELANDER A, 1977, CLIN PHARMACOL THER, V22, P104

[9]

OBOYLE CP, 1981, IRISH MED J, V74, P115

[10]

OLSON W, 1978, CLIN PHARMACOL THER, V23, P204

← 1 2 3 →